Salerno Pharmaceuticals, LP — Form D/A
Salerno Pharmaceuticals, LP of NEWPORT BEACH, CA, a company, filed a Form D amendment with the SEC on 2017-02-27. The offering totals $5.5M, of which $5.5M was reported sold. Industry: Pharmaceuticals.
Offering
- Filed: 2017-02-27
- Form: D/A
- Accession: 0001694399-17-000002
- Industry: Pharmaceuticals
- Exemptions: 06b
- Total offering: $5.5M
- Amount sold: $5.5M
- Investors: 41
- Date of first sale: 2017-02-16
- Security types: equity
- Revenue range: No Revenues
- SEC file number: 021-278478
Issuer
- Name: Salerno Pharmaceuticals, LP
- CIK: 0001694399
- Entity type: Limited Partnership
- Jurisdiction: DELAWARE
- Incorporated: 2016
- Address: 610 NEWPORT CENTER DRIVE, NEWPORT BEACH, CA, 92660
- Phone: 949-706-3600
Officers, directors & promoters (2)
| Name | Role | Location |
|---|
| Edward W McKenna | Executive Officer | Newport Beach, CA |
| Thomas W Courtney, Jr. | Executive Officer | Newport Beach, CA |
Other filings by this issuer (2)
More